High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2110-5820
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients ; volume:9 ; number:1 ; day:13 ; month:6 ; year:2019 ; pages:1-9 ; date:12.2019
Annals of intensive care ; 9, Heft 1 (13.6.2019), 1-9, 12.2019
- Urheber
-
Tanaka, Sébastien
Diallo, Dévy
Delbosc, Sandrine
Genève, Claire
Zappella, Nathalie
Yong-Sang, Jennyfer
Patche, Jessica
Harrois, Anatole
Hamada, Sophie
Denamur, Erick
Montravers, Philippe
Duranteau, Jacques
Meilhac, Olivier
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13613-019-0541-8
- URN
-
urn:nbn:de:101:1-2019112603295495709341
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tanaka, Sébastien
- Diallo, Dévy
- Delbosc, Sandrine
- Genève, Claire
- Zappella, Nathalie
- Yong-Sang, Jennyfer
- Patche, Jessica
- Harrois, Anatole
- Hamada, Sophie
- Denamur, Erick
- Montravers, Philippe
- Duranteau, Jacques
- Meilhac, Olivier
- SpringerLink (Online service)
Ähnliche Objekte (12)
Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution
Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer
Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL) 2 and the larger HDL 3 from very low-density lipoprotein (VLDL)
High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery
Presepsis biomarker: high-density lipoprotein
Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial
Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution
Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer
Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL) 2 and the larger HDL 3 from very low-density lipoprotein (VLDL)
High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery
Presepsis biomarker: high-density lipoprotein
Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial
Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution
Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer
Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL) 2 and the larger HDL 3 from very low-density lipoprotein (VLDL)
High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery
Presepsis biomarker: high-density lipoprotein
Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)